Published in Lancet Infect Dis on December 01, 2001
Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex. Emerg Infect Dis (2005) 3.32
Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: resistance is a regional problem. Proc Natl Acad Sci U S A (2004) 2.57
Restricted gene flow among hospital subpopulations of Enterococcus faecium. MBio (2012) 1.92
Strategic interactions in multi-institutional epidemics of antibiotic resistance. Proc Natl Acad Sci U S A (2005) 1.92
Multiple-locus variable-number tandem repeat analysis, a novel typing scheme to study the genetic relatedness and epidemiology of Enterococcus faecium isolates. J Clin Microbiol (2004) 1.69
Population biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistance. FEMS Microbiol Rev (2011) 1.66
Two-center collaborative evaluation of the performance of the BD Phoenix automated microbiology system for identification and antimicrobial susceptibility testing of Enterococcus spp. and Staphylococcus spp. J Clin Microbiol (2003) 1.56
Spread of ampicillin/vancomycin-resistant Enterococcus faecium of the epidemic-virulent clonal complex-17 carrying the genes esp and hyl in German hospitals. Eur J Clin Microbiol Infect Dis (2005) 1.51
Emergence of clonal complex 17 Enterococcus faecium in The Netherlands. J Clin Microbiol (2007) 1.45
Agricultural antibiotics and human health. PLoS Med (2005) 1.31
The anti-sigma factor TcdC modulates hypervirulence in an epidemic BI/NAP1/027 clinical isolate of Clostridium difficile. PLoS Pathog (2011) 1.28
Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management. Infect Drug Resist (2015) 1.27
Comparative analysis of the first complete Enterococcus faecium genome. J Bacteriol (2012) 1.27
Population structure of Enterococcus faecium causing bacteremia in a Spanish university hospital: setting the scene for a future increase in vancomycin resistance? Antimicrob Agents Chemother (2005) 1.24
Modeling antibiotic resistance in hospitals: the impact of minimizing treatment duration. J Theor Biol (2007) 1.24
High-level ciprofloxacin resistance from point mutations in gyrA and parC confined to global hospital-adapted clonal lineage CC17 of Enterococcus faecium. J Clin Microbiol (2006) 1.17
Local genetic patterns within a vancomycin-resistant Enterococcus faecalis clone isolated in three hospitals in Portugal. Antimicrob Agents Chemother (2004) 1.15
Do we need to put society first? The potential for tragedy in antimicrobial resistance. PLoS Med (2006) 1.14
Response to emerging infection leading to outbreak of linezolid-resistant enterococci. Emerg Infect Dis (2007) 1.13
Antibiotic use in Hispanic households, New York city. Emerg Infect Dis (2003) 1.11
Prevalence and antimicrobial resistance of Enterococcus species: a hospital-based study in China. Int J Environ Res Public Health (2014) 1.07
Molecular characterization of ampicillin-resistant Enterococcus faecium isolates from hospitalized patients in Norway. J Clin Microbiol (2003) 1.07
VanA-type enterococci from humans, animals, and food: species distribution, population structure, Tn1546 typing and location, and virulence determinants. Appl Environ Microbiol (2007) 1.03
Neutrophils are essential for rapid clearance of Enterococcus faecium in mice. Infect Immun (2008) 1.01
In silico and in vivo evaluation of bacteriophage phiEF24C, a candidate for treatment of Enterococcus faecalis infections. Appl Environ Microbiol (2008) 0.99
Diversity of Tn1546 and its role in the dissemination of vancomycin-resistant enterococci in Portugal. Antimicrob Agents Chemother (2008) 0.99
Core Genome Multilocus Sequence Typing Scheme for High- Resolution Typing of Enterococcus faecium. J Clin Microbiol (2015) 0.99
Enterococcus faecalis overcomes foreign body-mediated inflammation to establish urinary tract infections. Infect Immun (2012) 0.98
Elevated risk of carrying gentamicin-resistant Escherichia coli among U.S. poultry workers. Environ Health Perspect (2007) 0.98
Comparative analysis of the complete genome of an epidemic hospital sequence type 203 clone of vancomycin-resistant Enterococcus faecium. BMC Genomics (2013) 0.98
Microevolutionary events involving narrow host plasmids influences local fixation of vancomycin-resistance in Enterococcus populations. PLoS One (2013) 0.97
Improved adsorption of an Enterococcus faecalis bacteriophage ΦEF24C with a spontaneous point mutation. PLoS One (2011) 0.97
Vancomycin-resistant enteroccus faecium and enterococcus faecalis isolated from education hospital of iran. Maedica (Buchar) (2014) 0.95
Population biology of intestinal enterococcus isolates from hospitalized and nonhospitalized individuals in different age groups. Appl Environ Microbiol (2014) 0.94
Production of the glycopeptide antibiotic A40926 by Nonomuraea sp. ATCC 39727: influence of medium composition in batch fermentation. J Ind Microbiol Biotechnol (2003) 0.93
Vancomycin revisited - 60 years later. Front Public Health (2014) 0.93
Vancomycin resistant enterococci in farm animals - occurrence and importance. Infect Ecol Epidemiol (2012) 0.92
Trends in susceptibility of vancomycin-resistant Enterococcus faecium to tigecycline, daptomycin, and linezolid and molecular epidemiology of the isolates: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2006 to 2010. Antimicrob Agents Chemother (2012) 0.92
Zinc and copper in animal feed - development of resistance and co-resistance to antimicrobial agents in bacteria of animal origin. Microb Ecol Health Dis (2014) 0.92
Characterization of vancomycin-resistant Enterococcus faecium isolates from broiler poultry and pig farms in England and Wales. J Clin Microbiol (2005) 0.91
Antibiotics in agriculture and the risk to human health: how worried should we be? Evol Appl (2014) 0.91
Detection of enterococcal surface protein gene (esp) and amplified fragment length polymorphism typing of glycopeptide-resistant Enterococcus faecium during its emergence in a Greek intensive care unit. J Clin Microbiol (2003) 0.89
Occurrence, population structure, and antimicrobial resistance of enterococci in marginal and apical periodontitis. J Clin Microbiol (2009) 0.89
High abundance and diversity of antimicrobial resistance determinants among early vancomycin-resistant Enterococcus faecium in Poland. Eur J Clin Microbiol Infect Dis (2013) 0.88
Molecular characterization of glycopeptide-resistant Enterococcus faecium isolates from Portuguese hospitals. Antimicrob Agents Chemother (2005) 0.88
Molecular analysis and distribution of multidrug-resistant Enterococcus faecium isolates belonging to clonal complex 17 in a tertiary care center in Mexico City. BMC Microbiol (2013) 0.86
Cloxacillin versus vancomycin for presumed late-onset sepsis in the Neonatal Intensive Care Unit and the impact upon outcome of coagulase negative staphylococcal bacteremia: a retrospective cohort study. BMC Pediatr (2005) 0.86
The vanB2 gene cluster of the majority of vancomycin-resistant Enterococcus faecium isolates from Taiwan is associated with the pbp5 gene and is carried by Tn5382 containing a novel insertion sequence. Antimicrob Agents Chemother (2005) 0.85
Impact of vancomycin resistance on mortality in neutropenic patients with enterococcal bloodstream infection: a retrospective study. BMC Infect Dis (2013) 0.84
Antimicrobial resistance gene delivery in animal feeds. Emerg Infect Dis (2004) 0.84
The Enterococcus faecalis exoproteome: identification and temporal regulation by Fsr. PLoS One (2012) 0.83
Regional spread and control of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Kyoto, Japan. Eur J Clin Microbiol Infect Dis (2011) 0.82
Enterococcus faecalis clones in poultry and in humans with urinary tract infections, Vietnam. Emerg Infect Dis (2012) 0.81
Drug-resistant and hospital-associated Enterococcus faecium from wastewater, riverine estuary and anthropogenically impacted marine catchment basin. BMC Microbiol (2014) 0.81
Vancomycin resistant enterococci (VRE) in Swedish sewage sludge. Acta Vet Scand (2009) 0.80
Characterization of antilisterial bacteriocins produced by Enterococcus faecium and Enterococcus durans isolates from Hispanic-style cheeses. J Ind Microbiol Biotechnol (2008) 0.80
Genetic modifications to temperate Enterococcus faecalis phage Ef11 that abolish the establishment of lysogeny and sensitivity to repressor, and increase host range and productivity of lytic infection. Microbiology (2013) 0.79
A novel termini analysis theory using HTS data alone for the identification of Enterococcus phage EF4-like genome termini. BMC Genomics (2015) 0.78
SalB inactivation modulates culture supernatant exoproteins and affects autolysis and viability in Enterococcus faecalis OG1RF. J Bacteriol (2012) 0.77
Muraymycin nucleoside-peptide antibiotics: uridine-derived natural products as lead structures for the development of novel antibacterial agents. Beilstein J Org Chem (2016) 0.77
Lactobacillus rhamnosus GG Outcompetes Enterococcus faecium via Mucus-Binding Pili: Evidence for a Novel and Heterospecific Probiotic Mechanism. Appl Environ Microbiol (2016) 0.76
Isolation and characterization of a novel bacteriophage φ4D lytic against Enterococcus faecalis strains. Curr Microbiol (2012) 0.76
Magnitude of enterococcal bacteremia in trauma patients admitted for intensive trauma care: a tertiary care experience from South asian country. J Lab Physicians (2015) 0.75
Virulence and antimicrobial resistance factors of Enterococcusspp. isolated from fecal samples from piggery farms in Eastern Cape, South Africa. BMC Microbiol (2015) 0.75
Intestinal colonization with Enterococcus faecium does not influence pulmonary defense against Pseudomonas aeruginosa in mice. PLoS One (2009) 0.75
Isolation of VanA-type vancomycin-resistant Enterococcus strains from domestic poultry products with enrichment by incubation in buffered peptone water at 42 degrees C. Appl Environ Microbiol (2010) 0.75
Antimicrobials in farming. CMAJ (2013) 0.75
The Risk of Some Veterinary Antimicrobial Agents on Public Health Associated with Antimicrobial Resistance and their Molecular Basis. Front Microbiol (2016) 0.75
Effect of a genetically engineered bacteriophage on Enterococcus faecalis biofilms. Arch Oral Biol (2016) 0.75
Selective decontamination of the digestive tract: all questions answered? Crit Care (2003) 0.75
Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA (1999) 5.26
Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals. A challenge to hospital leadership. JAMA (1996) 4.80
Colonization of skilled-care facility residents with antimicrobial-resistant pathogens. J Am Geriatr Soc (2001) 3.06
The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med (1998) 2.94
Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs. Proc Natl Acad Sci U S A (1999) 2.75
Transfusion-associated acquired immunodeficiency syndrome. Evidence for persistent infection in blood donors. N Engl J Med (1985) 2.62
Development of Daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2005) 2.53
Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation. J Infect Dis (1996) 2.49
Identity and interspecific transfer of gentamicin-resistance plasmids in Staphylococcus aureus and Staphylococcus epidermidis. J Infect Dis (1980) 2.48
Are active microbiological surveillance and subsequent isolation needed to prevent the spread of methicillin-resistant Staphylococcus aureus? Clin Infect Dis (2005) 2.47
Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet (1996) 2.44
A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med (1996) 2.38
Medical and surgical treatment of parapneumonic effusions : an evidence-based guideline. Chest (2000) 2.36
Genetically diverse ceftazidime-resistant isolates from a single center: biochemical and genetic characterization of TEM-10 beta-lactamases encoded by different nucleotide sequences. Antimicrob Agents Chemother (1993) 2.03
Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program. Clin Infect Dis (1996) 2.03
Epidemics of nosocomial urinary tract infection caused by multiply resistant gram-negative bacilli: epidemiology and control. J Infect Dis (1976) 1.92
Structural and phenotypic varieties of gentamicin resistance plasmids in hospital strains of Staphylococcus aureus and coagulase-negative staphylococci. Antimicrob Agents Chemother (1982) 1.89
Pseudoepidemics in hospital. Lancet (1977) 1.89
Lower than expected desmosomal gene mutation prevalence in endurance athletes with complex ventricular arrhythmias of right ventricular origin. Heart (2010) 1.82
Breast abscess: coagulase-negative staphylococcus as a sole pathogen. Clin Infect Dis (1993) 1.72
Unnoticed spread of integron-carrying Enterobacteriaceae in intensive care units. Clin Infect Dis (2005) 1.66
External sources of vancomycin-resistant enterococci for intensive care units. Crit Care Med (1998) 1.59
Hospital outbreaks caused by Pseudomonas aeruginosa: importance of serogroup O11. J Clin Microbiol (1982) 1.58
Enterococci with glycopeptide resistance in turkeys, turkey farmers, turkey slaughterers, and (sub)urban residents in the south of The Netherlands: evidence for transmission of vancomycin resistance from animals to humans? Antimicrob Agents Chemother (1999) 1.56
Gentamicin-resistant staphylococci as hospital flora: epidemiology and resistance plasmids. J Infect Dis (1982) 1.54
Association of infection caused by Pseudomonas aeruginosa serotype O11 with intravenous abuse of pentazocine mixed with tripelennamine. J Clin Microbiol (1984) 1.54
AIDS-related Pneumocystis carinii pneumonia in older patients. J Gen Intern Med (1996) 1.54
Stability of vancomycin-resistant enterococcal genotypes isolated from long-term-colonized patients. J Infect Dis (1998) 1.53
Variations in intensive care unit utilization for patients with human immunodeficiency virus-related Pneumocystis carinii pneumonia: importance of hospital characteristics and geographic location. Crit Care Med (1998) 1.52
Patients' endogenous flora as the source of "nosocomial" Enterobacter in cardiac surgery. J Infect Dis (1987) 1.49
Relationship between procedures and health insurance for critically ill patients with Pneumocystis carinii pneumonia. Am J Respir Crit Care Med (1995) 1.48
Epidemiology of endemic Pseudomonas aeruginosa: why infection control efforts have failed. J Infect Dis (1984) 1.46
Diphtheria in the United States, 1971-81. Am J Public Health (1985) 1.44
Early detection of false-positive acid-fast smears. An epidemiological approach. Lancet (1975) 1.39
Magnitude and prevention of nosocomial infections in the intensive care unit. Infect Dis Clin North Am (1997) 1.37
Effectiveness of gloves in the prevention of hand carriage of vancomycin-resistant enterococcus species by health care workers after patient care. Clin Infect Dis (2001) 1.36
Variations in institutional review board decisions for HIV quality of care studies: a potential source of study bias. J Acquir Immune Defic Syndr (2001) 1.36
Pressure monitoring devices. Overlooked source of nosocomial infection. JAMA (1976) 1.31
Antibiotic resistance of faecal enterococci in poultry, poultry farmers and poultry slaughterers. J Antimicrob Chemother (2002) 1.31
Comparison of endemic and epidemic nosocomial infections. Am J Med (1981) 1.31
Improvements in outcomes of acute respiratory failure for patients with human immunodeficiency virus-related Pneumocystis carinii pneumonia. Am J Respir Crit Care Med (2000) 1.30
Multiresistant bacteria as a hospital epidemic problem. Ann Med (1998) 1.27
Endemic emergence of cephalosporin-resistant Enterobacter: relation to prior therapy. Infect Control (1986) 1.26
[Vancomycin-resistant Enterococcus faecium outbreak in a nephrology ward]. Ned Tijdschr Geneeskd (2000) 1.24
Broad-spectrum beta-lactam resistance in Enterobacter: emergence during treatment and mechanisms of resistance. J Antimicrob Chemother (1983) 1.24
Ecological replacement of Enterococcus faecalis by multiresistant clonal complex 17 Enterococcus faecium. Clin Microbiol Infect (2007) 1.23
An outbreak of pneumocystis pneumonia in children with acute lymphocytic leukemia. Am J Dis Child (1978) 1.22
Pericardial effusion and right-sided pneumothorax resulting from an atrial active-fixation lead. Europace (2003) 1.20
Endemic aminoglycoside resistance in gram-negative bacilli: epidemiology and mechanisms. J Infect Dis (1980) 1.20
Occult aminoglycoside resistance in Pseudomonas aeruginosa: epidemiology and implications for therapy and control. J Infect Dis (1985) 1.19
The epidemiology of Pseudomonas aeruginosa in oncology patients in a general hospital. J Infect Dis (1989) 1.17
Prevention of peripheral venous catheter complications with an intravenous therapy team: a randomized controlled trial. Arch Intern Med (1998) 1.17
Patients with an unexplained microsatellite instable tumour have a low risk of familial cancer. Br J Cancer (2007) 1.16
Right atrial angiographic evaluation of the posterior isthmus: relevance for ablation of typical atrial flutter. Circulation (2000) 1.14
[What is to be done with vancomycin-resistant enterococcal infections?]. Ned Tijdschr Geneeskd (2000) 1.13
Skin colonization with vancomycin-resistant enterococci among hospitalized patients with bacteremia. Clin Infect Dis (1997) 1.11
Nucleoside diphosphate kinase (NDPK/NM23) and the waltz with multiple partners: possible consequences in tumor metastasis. Clin Exp Metastasis (2002) 1.10
Antibiotic-resistant flora in nursing home patients admitted to the hospital. Arch Intern Med (1985) 1.10
Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat. Brain Res (1988) 1.10
The changing molecular epidemiology and establishment of endemicity of vancomycin resistance in enterococci at one hospital over a 6-year period. J Infect Dis (1999) 1.10
Bowel colonization with resistant gram-negative bacilli after antimicrobial therapy of intra-abdominal infections: observations from two randomized comparative clinical trials of ertapenem therapy. Eur J Clin Microbiol Infect Dis (2005) 1.09
Racial differences in care among hospitalized patients with Pneumocystis carinii pneumonia in Chicago, New York, Los Angeles, Miami, and Raleigh-Durham. Arch Intern Med (1995) 1.09
Lessons from an epidemic, again. N Engl J Med (2001) 1.07
Risk factors for antibiotic-resistant infection and treatment outcomes among hospitalized patients transferred from long-term care facilities: does antimicrobial choice make a difference? Clin Infect Dis (2003) 1.06
Reactive hemophagocytic syndrome: a new presentation of disseminated histoplasmosis in patients with AIDS. Clin Infect Dis (1995) 1.06
The superfast atrial recharge pulse: a cause of pectoral muscle stimulation in patients equipped with a unipolar DDD pacemaker. Pacing Clin Electrophysiol (1989) 1.06
Strategies for prevention and control of multiple drug-resistant nosocomial infection. Am J Med (1981) 1.04
Pressure transducers as a source of bacteremia after open heart surgery. Report of an outbreak and guidelines for prevention. Chest (1976) 1.03
Control of aminoglycoside resistance by barrier precautions. Infect Control (1983) 1.01
The role of colonization in the pathogenesis of nosocomial infections. Infect Control Hosp Epidemiol (1996) 1.01
Genetic and phenotypic differences among Enterococcus faecalis clones from intestinal colonisation and invasive disease. Clin Microbiol Infect (2006) 1.01
Very low incidence of microsatellite instability in rectal cancers from families at risk for HNPCC. Clin Genet (2003) 1.01
Caribbean sponge-related Pseudomonas folliculitis. JAMA (1987) 1.01
The case for face masks-zorro or zero? Clin Infect Dis (2000) 1.00
Hairy cell leukemia: association with disseminated atypical mycobacterial infection. Cancer (1981) 1.00
High-level transgene expression in primary human T lymphocytes and adult bone marrow CD34+ cells via electroporation-mediated gene delivery. Gene Ther (2000) 0.99
A new preadmission staging system for predicting inpatient mortality from HIV-associated Pneumocystis carinii pneumonia in the early highly active antiretroviral therapy (HAART) era. Am J Respir Crit Care Med (2000) 0.99
Pilot trial of selective decontamination for prevention of bacterial infection in an intensive care unit. J Infect Dis (1990) 0.98
The effect of renal dysfunction on antimicrobial use measurements. Clin Infect Dis (2002) 0.98
Factitious meningitis. Diagnostic error due to nonviable bacteria in commercial lumbar puncture trays. JAMA (1975) 0.96
Delays in tuberculosis isolation and suspicion among persons hospitalized with HIV-related pneumonia. Chest (2000) 0.96
Infection control in intensive care units and prevention of ventilator-associated pneumonia. Semin Respir Infect (2000) 0.96
Nosocomial infection caused by antibiotic-resistant organisms in the intensive-care unit. Infect Control Hosp Epidemiol (1996) 0.96
Pseudomonas in the sinks in an intensive care unit: relation to patients. J Clin Pathol (1984) 0.95
In-vitro resistance to zidovudine and alpha-interferon in HIV-1 isolates from patients: correlations with treatment duration and response. Ann Intern Med (1992) 0.93
The comparative in vitro activity of clinafloxacin and other antimicrobials against vancomycin-susceptible and vancomycin-resistant enterococci. Chemotherapy (1997) 0.93
"Curbside" consultation and informal communication in medical practice: a medicolegal perspective. Clin Infect Dis (1996) 0.93
Interventional evaluation of environmental contamination by vancomycin-resistant enterococci: failure of personnel, product, or procedure? J Hosp Infect (2008) 0.92
Meningorectal fistula as a cause of polymicrobial anaerobic meningitis. Am J Clin Pathol (1982) 0.91
Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients. Am J Med (1989) 0.91
Eosinophilic meningitis and ibuprofen therapy. Neurology (1984) 0.90
A randomized, double-blind, placebo-controlled trial of selective digestive decontamination in a medical-surgical intensive care unit. Clin Infect Dis (1995) 0.89
Post-flood measurement of fungal bio-aerosol in a resource-limited hospital: can the settle plate method be used? J Hosp Infect (2013) 0.89
HIV-related Pneumocystis carinii pneumonia in older patients hospitalized in the early HAART era. J Gen Intern Med (2001) 0.89
SHEA consensus panel report: a smooth takeoff. Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol (1998) 0.89
Infections with gram-negative bacilli in a cardiac surgery intensive care unit: the relative role of enterobacter. J Hosp Infect (1988) 0.89
Multi-hospital analysis of antimicrobial usage and resistance trends. Diagn Microbiol Infect Dis (2001) 0.88
Differentiation-dependent expression of provirus-activated int-1 oncogene in clonal cell lines derived from a mouse mammary tumor. Oncogene (1990) 0.88
Interferon-alpha plus zidovudine in HIV infection. Lancet (1989) 0.88